BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20104168)

  • 1. Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia.
    Motta F; Antonello CE; Stignani C
    J Pediatr Orthop; 2009; 29(7):817-21. PubMed ID: 20104168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales.
    Motta F; Stignani C; Antonello CE
    J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper limb function after intrathecal baclofen treatment in children with cerebral palsy.
    Motta F; Stignani C; Antonello CE
    J Pediatr Orthop; 2008; 28(1):91-6. PubMed ID: 18157052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intrathecal baclofen on daily care in children with secondary generalized dystonia: a pilot study.
    BonouvriƩ LA; van Schie PE; Becher JG; van Ouwerkerk WJ; Reeuwijk A; Jeroen Vermeulen R
    Eur J Paediatr Neurol; 2011 Nov; 15(6):539-43. PubMed ID: 21628102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
    Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.
    Krach LE; Kriel RL; Day SM; Strauss DJ
    Dev Med Child Neurol; 2010 Jul; 52(7):672-6. PubMed ID: 19811519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intrathecal baclofen in the management of primary and secondary dystonia in children.
    Woon K; Tsegaye M; Vloeberghs MH
    Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
    Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
    Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological assessment of the effect of intrathecal baclofen in dystonic children.
    Dachy B; Dan B
    Clin Neurophysiol; 2004 Apr; 115(4):774-8. PubMed ID: 15003756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children.
    Albright AL; Awaad Y; Muhonen M; Boydston WR; Gilmartin R; Krach LE; Turner M; Zidek KA; Wright E; Swift D; Bloom K
    J Neurosurg; 2004 Aug; 101(1 Suppl):64-8. PubMed ID: 16206974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity.
    Eek MN; Olsson K; Lindh K; Askljung B; PĆ„hlman M; Corneliusson O; Himmelmann K
    Dev Med Child Neurol; 2018 Jan; 60(1):94-99. PubMed ID: 29148568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
    Brochard S; Remy-Neris O; Filipetti P; Bussel B
    Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
    Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
    Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy.
    Bleyenheuft C; Filipetti P; Caldas C; Lejeune T
    Neurophysiol Clin; 2007; 37(1):23-8. PubMed ID: 17418354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen for dystonia of complex regional pain syndrome.
    van Rijn MA; Munts AG; Marinus J; Voormolen JH; de Boer KS; Teepe-Twiss IM; van Dasselaar NT; Delhaas EM; van Hilten JJ
    Pain; 2009 May; 143(1-2):41-7. PubMed ID: 19232828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal baclofen use in adults with cerebral palsy.
    Krach LE
    Dev Med Child Neurol; 2009 Oct; 51 Suppl 4():106-12. PubMed ID: 19740217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of intrathecal baclofen pump therapy in pediatric patients.
    Borowski A; Littleton AG; Borkhuu B; Presedo A; Shah S; Dabney KW; Lyons S; McMannus M; Miller F
    J Pediatr Orthop; 2010; 30(1):76-81. PubMed ID: 20032747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy.
    McCoy AA; Fox MA; Schaubel DE; Ayyangar RN
    Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.